Atlas Trials

PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Clinical trial NCT05501340 · UNKNOWN

Trial details

NCT number
NCT05501340
Sponsor
Second Affiliated Hospital of Soochow University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Malignant Ascites
Start date
2022-09-01
Primary completion
2022-12-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.